Chronic daily dosing of PDE5 inhibitors (sildenafil or tadalafil) for pulmonary hypertension and risk of subsequent melanoma: A report from the Research on Adverse Drug Events and Reports (RADAR) project - 03/08/18
Beatrice Nardone, MD, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Linda Serrano, MD, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Kelsey A. Orrell, MBBCh, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Ryan C. Kelm, BS, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Giuliana Zaccardelli, BA, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Rema Zebda, MD, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Krishna Patel, MD, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Stephanie M. Rangel, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Anne E. Laumann, MBChB, Department of Dermatology, Feinberg School of Medicine, Northwestern University; Dennis P. West, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 79 - N° 3S1
P. AB72 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?